News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
538,595 Results
Type
Article (33877)
Company Profile (160)
Press Release (504558)
Section
Business (155008)
Career Advice (740)
Deals (25274)
Drug Delivery (69)
Drug Development (59690)
Employer Resources (79)
FDA (14260)
Job Trends (11893)
News (259664)
Policy (24154)
Tag
2024 BioCapital Digital (2)
2024 BioForest Digital (8)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (6)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (11)
2024 Biotech Beach Digital (6)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (1)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (3)
2025 Lone Star Bio Digital (4)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (2300)
Accelerated approval (3)
Adcomms (8)
Allergies (80)
Alliances (43467)
ALS (62)
Alzheimer's disease (1021)
Antibody-drug conjugate (ADC) (84)
Approvals (14300)
Artificial intelligence (245)
Autoimmune disease (10)
Automation (11)
Bankruptcy (211)
Best Places to Work (9747)
BIOSECURE Act (9)
Biosimilars (42)
Biotechnology (117)
Bladder cancer (48)
Brain cancer (21)
Breast cancer (205)
Cancer (1611)
Cardiovascular disease (127)
Career advice (662)
Career pathing (17)
CAR-T (123)
Cell therapy (328)
Cervical cancer (19)
Clinical research (48924)
Collaboration (690)
Compensation (192)
Complete response letters (11)
COVID-19 (2002)
CRISPR (36)
C-suite (185)
Cystic fibrosis (72)
Data (1654)
Decentralized trials (2)
Denatured (25)
Depression (32)
Diabetes (193)
Diagnostics (5809)
Digital health (16)
Diversity (7)
Diversity, equity & inclusion (17)
Drug discovery (96)
Drug pricing (61)
Drug shortages (23)
Duchenne muscular dystrophy (56)
Earnings (54749)
Editorial (20)
Employer branding (12)
Employer resources (70)
Events (76635)
Executive appointments (544)
FDA (15281)
Featured Employer (35)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (3)
Funding (571)
Gene editing (90)
Generative AI (24)
Gene therapy (215)
GLP-1 (502)
Government (3441)
Grass and pollen (4)
Guidances (41)
Healthcare (15568)
Huntington's disease (11)
IgA nephropathy (19)
Immunology and inflammation (49)
Indications (21)
Infectious disease (2104)
Inflammatory bowel disease (102)
Inflation Reduction Act (5)
Influenza (41)
Intellectual property (72)
Interviews (77)
IPO (10929)
IRA (23)
Job creations (2562)
Job search strategy (595)
Kidney cancer (7)
Labor market (14)
Layoffs (244)
Leadership (6)
Legal (4954)
Liver cancer (59)
Lung cancer (243)
Lymphoma (102)
Machine learning (3)
Management (29)
Manufacturing (198)
MASH (50)
Medical device (14005)
Medtech (14010)
Mergers & acquisitions (14736)
Metabolic disorders (478)
Multiple sclerosis (56)
NASH (12)
Neurodegenerative disease (58)
Neuropsychiatric disorders (11)
Neuroscience (1385)
NextGen: Class of 2025 (5398)
Non-profit (3400)
Northern California (1745)
Now hiring (19)
Obesity (239)
Opinion (122)
Ovarian cancer (61)
Pain (73)
Pancreatic cancer (61)
Parkinson's disease (105)
Partnered (15)
Patents (167)
Patient recruitment (84)
Peanut (47)
People (47425)
Pharmaceutical (32)
Pharmacy benefit managers (11)
Phase I (15132)
Phase II (21379)
Phase III (16510)
Pipeline (799)
Podcasts (52)
Policy (67)
Postmarket research (1808)
Preclinical (5883)
Press Release (67)
Prostate cancer (77)
Psychedelics (18)
Radiopharmaceuticals (213)
Rare diseases (240)
Real estate (4619)
Recruiting (30)
Regulatory (17345)
Reports (18)
Research institute (2080)
Resumes & cover letters (100)
Rett syndrome (4)
RNA editing (2)
RSV (29)
Schizophrenia (50)
Series A (98)
Series B (63)
Service/supplier (8)
Sickle cell disease (31)
Southern California (1593)
Special edition (4)
Spinal muscular atrophy (117)
Sponsored (21)
Startups (3205)
State (2)
Stomach cancer (9)
Supply chain (43)
Tariffs (3)
The Weekly (26)
United States (16382)
Vaccines (511)
Venture capitalists (25)
Webinars (10)
Weight loss (156)
Women's health (24)
Worklife (6)
Date
Last 7 days (490)
Last 30 days (1913)
Last 365 days (26154)
2025 (6412)
2024 (27751)
2023 (31915)
2022 (42306)
2021 (45750)
2020 (44558)
2019 (39088)
2018 (29737)
2017 (26811)
2016 (25741)
2015 (30022)
2014 (22806)
2013 (19194)
2012 (20786)
2011 (21274)
2010 (19632)
Location
Africa (517)
Alabama (43)
Alaska (6)
Arizona (170)
Arkansas (13)
Asia (33725)
Australia (5714)
California (4094)
Canada (1560)
China (417)
Colorado (192)
Connecticut (217)
Delaware (111)
Europe (71353)
Florida (674)
Georgia (171)
Idaho (48)
Illinois (413)
India (17)
Indiana (246)
Iowa (5)
Japan (136)
Kansas (99)
Kentucky (15)
Louisiana (6)
Maine (33)
Maryland (725)
Massachusetts (2895)
Michigan (213)
Minnesota (309)
Mississippi (2)
Missouri (70)
Montana (27)
Nebraska (23)
Nevada (36)
New Hampshire (66)
New Jersey (1313)
New Mexico (20)
New York (1206)
North Carolina (747)
North Dakota (8)
Northern California (1745)
Ohio (164)
Oklahoma (11)
Oregon (30)
Pennsylvania (935)
Puerto Rico (9)
Rhode Island (26)
South America (770)
South Carolina (19)
South Dakota (1)
Southern California (1593)
Tennessee (79)
Texas (643)
Utah (147)
Virginia (93)
Washington D.C. (39)
Washington State (414)
West Virginia (3)
Wisconsin (48)
538,595 Results for "helius medical technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Helius Medical Technologies, Inc. Announces the Establishment of a Wholly Owned Brain Computer Interface (“BCI”) Technology Private Subsidiary
March 13, 2025
·
5 min read
Press Releases
Helius Medical Technologies, Inc. Announces First Reimbursement by A Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) Device
March 11, 2025
·
5 min read
Pharm Country
Helius Medical Technologies, Inc. to Present at the Spring MicroCap Rodeo Conference 2024
Helius Medical Technologies, Inc. announced that it will participate in the Spring MicroCap Rodeo Conference to be held on Thursday, June 6th in NYC.
May 31, 2024
·
6 min read
Press Releases
Helius Medical Technologies, Inc. Announces Strong Enrollment of its Stroke Pivotal Study Exceeding Initial Target
January 21, 2025
·
8 min read
Business
Helius Medical Technologies, Inc. Reports First Quarter 2024 Financial Results
Helius Medical Technologies, Inc., a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, announced results for the quarter ended March 31, 2024.
May 13, 2024
·
10 min read
News
Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference
October 18, 2024
·
1 min read
Pharm Country
Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd Center
Helius Medical Technologies, Inc. today announced the expansion of its clinical development program for the broadening of the labeling of its marketed PoNS device.
April 24, 2024
·
7 min read
Pharm Country
Helius Medical Technologies, Inc. Completes Site Participation Enrollment for its U.S. Registrational Program in Stroke
Helius Medical Technologies, Inc. announced the completion of site participation enrollment for its stroke registrational program in the U.S. with the addition of REHABOLOGYM, Neurology Center of New England, and MGH Institute of Health Professions.
June 17, 2024
·
10 min read
Business
Helius Medical Technologies, Inc. to Release First Quarter 2024 Financial Results on May 13, 2024
Helius Medical Technologies, Inc. today announced that the Company will release its first quarter 2024 financial results on Monday, May 13, 2024, after the market closes.
May 10, 2024
·
2 min read
Pharm Country
Helius Medical Technologies, Inc. Announces Third-Party Reimbursement for PoNS® from Major Insurance Carrier
Helius Medical Technologies, Inc., a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, announced the first third-party reimbursement from a major insurance carrier for the Company’s Portable Neuromodulation Stimulator device.
May 29, 2024
·
5 min read
1 of 53,860
Next
